Correlation Between ANI Pharmaceuticals and Lantheus Holdings

Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Lantheus Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Lantheus Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ANI Pharmaceuticals and Lantheus Holdings, you can compare the effects of market volatilities on ANI Pharmaceuticals and Lantheus Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Lantheus Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Lantheus Holdings.

Diversification Opportunities for ANI Pharmaceuticals and Lantheus Holdings

0.41

Correlation Coefficient

ANI Pharmaceuticals  Lantheus Holdings

Very weak diversification

The 3 months correlation between ANI and Lantheus is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Lantheus Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantheus Holdings and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Lantheus Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantheus Holdings has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Lantheus Holdings go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and Lantheus Holdings

Given the investment horizon of 90 days ANI Pharmaceuticals is expected to generate 0.77 times more return on investment than Lantheus Holdings. However, ANI Pharmaceuticals is 1.3 times less risky than Lantheus Holdings. It trades about 0.16 of its potential returns per unit of risk. Lantheus Holdings is currently generating about 0.06 per unit of risk. If you would invest  5,421  in ANI Pharmaceuticals on December 28, 2024 and sell it today you would earn a total of  1,340  from holding ANI Pharmaceuticals or generate 24.72% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ANI Pharmaceuticals  vs.  Lantheus Holdings

ANI Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ANI Pharmaceuticals are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak forward indicators, ANI Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Lantheus Holdings

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Lantheus Holdings are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Lantheus Holdings may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with ANI Pharmaceuticals and Lantheus Holdings

The main advantage of trading using opposite ANI Pharmaceuticals and Lantheus Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Lantheus Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantheus Holdings will offset losses from the drop in Lantheus Holdings' long position.

The idea behind ANI Pharmaceuticals and Lantheus Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.